vilobelimab (Investigational)

Brand and Other Names:
  • Print

Dosing & Uses

COVID-19 Disease

EUA pending for treatment of critically ill, invasively mechanically ventilated patients with COVID-19

Next:

Pharmacology

Mechanism of Action

Monoclonal anti-human complement factor C5a antibody

Blocks the biological inflammatory activity of C5a, while leaving formation of the membrane attack complex (C5b-9) intact as an important defense mechanism

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.